IN-VIVO ACTIVITY OF TYROSINE-HYDROXYLASE IN RAT ADRENAL-GLANDS FOLLOWING ADMINISTRATION OF QUINPIROLE AND DOPAMINE

被引:8
作者
KUJACIC, M
CARLSSON, A
机构
[1] Department of Pharmacology, University of Göteborg, S-413 90 Göteborg
关键词
DOPAMINE; DOPAMINE RECEPTOR AGONIST; CATECHOLAMINE; SYNTHESIS; DOPA (3,4-DIHYDROXYPHENYLALANINE), ACCUMULATION; ADRENAL MEDULLA;
D O I
10.1016/0014-2999(95)00092-Y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using adrenal dopamine as indicator we have previously obtained evidence that quinpirole and several other agonists on dopamine D-2-like receptors acutely stimulate the synthesis of adrenal catecholamines. In the present study we measured the effect of quinpirole and dopamine on the hydroxylation of tyrosine in the adrenals, using the method of DOPA (3,4-dihydroxyphenylalanine) accumulation following the administration of the inhibitor of aromatic L-amino acid decarboxylase NSD 1015 (3-hydroxybenzylhydrazyne). In view of the large amounts of catecholamines in the adrenal tissue samples, this necessitated a modification of the method for analysing DOPA. Both quinpirole and dopamine significantly enhanced the rate of DOPA accumulation in the adrenals, indicating stimulation of adrenal tyrosine hydroxylase. The effect of dopamine was blocked by domperidone, a dopamine D-2 receptor antagonist that penetrates poorly into the central nervous system. Thus the effect of dopamine, which itself penetrates poorly into the central nervous system, was presumably mediated peripherally. Similarly epinine, i.e. the N-methyl derivative of dopamine, appeared to enhance adrenal catecholamine synthesis, as indicated by an elevated adrenal dopamine level. The data support the view that stimulation of peripherally located dopamine D-2-like receptors can enhance the rate of adrenal catecholamine synthesis by stimulating the activity of tyrosine hydroxylase.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 14 条
[1]  
Atack, Magnusson, A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using a single column of strongly acidic cation exchange resin, Acta Pharmacol. Toxicol., 42, (1978)
[2]  
Bridgers, Kaufman, The enzymatic conversion of epinine to epinephrine, J. Biol. Chem., 237, (1962)
[3]  
Carlsson, Davis, Kehr, Lindqvist, Atack, Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase, Naunyn-Schmied. Arch. Pharmacol., 275, (1972)
[4]  
Casagrande, Merlo, Ferrini, Miragoli, Semeraro, Cardiovascular and renal action of dopaminergic prodrugs, J. Cardiovasc. Pharmacol., 14, (1989)
[5]  
Hayashi, Miwa, Lee, Koshimura, Kamei, Hamahata, Fujiwara, A nonisotopic method for determination of the in vivo activities of tyrosine hydroxylase in the rat adrenal gland, Anal. Biochem., 168, (1988)
[6]  
Itoh, Clinical pharmacology of ibopamine, The American Journal of Medicine, 90, (1991)
[7]  
Kehr, Carlsson, Lindqvist, A method for the determination of 3,4-dihydroxyphenylalanyne (DOPA) in brain, Naunyn-Schmied. Arch. Pharmacol., 274, (1972)
[8]  
Kujacic, Carlsson, Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors, J. Neural Transm. [Gen. Sect.], 92, (1993)
[9]  
Kujacic, Svensson, Lofberg, Carlsson, Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists, Eur. J. Pharmacol., 177, (1990)
[10]  
Kujacic, Svensson, Lofberg, Carlsson, Dopamine receptors, controlling dopamine levels in rat adrenal glands — comparison with central dopaminergic autoreceptors, J. Neural Transm. [Gen. Sect.], 84, (1991)